Niagen Bioscience (NAGE) Earnings Analysis
Niagen Bioscience (NAGE) has no confirmed upcoming earnings date. Last quarter (2026-03-04) it beat with EPS 0.03 USD vs 0.02 USD est (+50%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E 14.49.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does NAGE next report earnings?
No confirmed upcoming earnings date is currently scheduled for NAGE. This page updates as the calendar is published.
NAGE earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-04 | 0.03 USD | 0.02 USD | +50% | Beat |
| 2025-03-04 | 0.03 USD | 0.02 USD | +50% | Beat |
| 2024-10-31 | 0.02 USD | 0.01 USD | +100% | Beat |
Beat rate: 3/3 (100%) over reported quarters with consensus data.
NAGE valuation and analyst view
| Trailing P/E | 14.49 |
|---|---|
| Trailing EPS | 0.2332 USD |
| Price / book | 3.30 |
| Dividend yield | 0.00% |
| Market cap | 0.27B |
| Analyst consensus | Buy (5 buy / 0 hold / 0 sell) |
| Avg price target | 10.5 USD |
Related research pages
Frequently asked questions
When is Niagen Bioscience (NAGE)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for NAGE. This page updates as the calendar is published.
Did NAGE beat earnings last quarter?
In its 2026-03-04 report, NAGE posted EPS of 0.03 USD versus a 0.02 USD estimate — a beat of 50%.
What is NAGE's earnings track record?
Over the last 3 reported quarters with consensus data, NAGE beat estimates 3 times (100%).
What is NAGE's current P/E ratio and EPS?
NAGE trades at a trailing P/E of 14.49 on trailing EPS of 0.23320443710349487 USD.
What do analysts rate NAGE?
Analyst consensus is "Buy" across 5 ratings (0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 10.5 USD.